On the stock market since 2016, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (-2% a year). Red columns mark years that ended in a loss.
The stock trades 51% below its peak. The market has trimmed its expectations for the company.
Sales run at $60.4M a year. A small number, but proof the product has real buyers.
It pays out $3.78 per share each year — regular cash for whoever holds the stock.
A loss of $70.7M against $60.4M in annual sales.
On our five-subject report card, JHJAX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: JHJAX is a high-risk stock — not yet profitable, and its future rides on its product catching on.